Business Unusual

When unicorns lose their horns

In the technology startup world 90% of projects will fail but investors can’t be sure which will be the one to succeed. When one does, the investment spikes, setting up expectations that a unicorn has been born.

Unicorns are exciting (or at least appear that way) and get lots of media coverage which adds to the hype (See the Hype Cycle) and attracts both those that want to help by getting a job or looking to find if they could copy the idea and try do the same.

Here is the story of a unicorn that may survive the current difficult period or will in time be shown to have never been an actual unicorn in the first place.

Theranos

A medical company that could run over 200 blood tests using the blood drawn from a pin prick and have the results in minutes sounds more like science fiction that fact (more on a tricorder below).

Theranos, a privately-owned medical company, set out to do that and with a $9 billion valuation appeared to have created something amazing. But tests have shown that the results are not as accurate as they needed to be.

The CEO, founder and 50% owner Elizabeth Holmes (32 in 2016), is the youngest female self-made billionaire.

She is an American and was a great student wanting to pursue medicine from early on. She lived for a time in China with her parents and then worked on a bird flu project in Singapore. She had a fear of needles and opted to pursue chemical engineering instead of medicine.

While studying at Stanford University she founded Theranos in 2003 at age 19. She left her studies to pursue the idea of doing extensive blood testing with a process that needed only a fraction of the usual volume of blood and much less time.

The device, called Edison, attracted significant investment (over $400 million, some reports say over $700 million) and partnerships with large companies to manage the blood testing on their behalf.

Holmes and Theranos have 100 patents on their methods and appeared to build on their breakthroughs to capture a significant segment of the medical testing market.

Then, in October 2015, the Wall Street Journal reported that the FDA had carried out an inspection that found the device was inaccurate and only approved its use for one test. It said that the rest of the tests msut be performed using traditional testing systems.

Since then there has been more bad news in the form of a criminal probe to determine if the device is able to do what it claims. The supposed technology and patents have existed for more than a decade now so it is understandable that research papers on the effectiveness and means for doing the tests should be made available (at least to authorities and the scientific community). However, none are currently available.

It would either appear that this unicorn has lost its horn or it is battling a very tough period that one investor claims is motivated by competitors wanting to limit the disruption to the industry.

If it can survive the challenges to its credibility, and demonstrate that it can do the tests accurately with just a pin prick's worth of blood, then Theranos will go on to become as well known as Google and Apple and make Elizabeth Holmes one of the richest people on the planet.

If not, it would serve as a footnote that progress is messy and that medicine, in particular, has had a tough time overcoming challenges to our health.

Time will tell, but as fewer and fewer unicorns are being discovered, venture capital is becoming more circumspect about how it will use the capital. It is significantly down from its high point at the end of 2015. It might mean a slow down for disruption as access to significant capital is a critical part for new start-ups to challenge the incumbents.

Tricorder x Prize

Star Trek fans will recall a device used to determine what was wrong with anyone without touching them. Qualcomm offered $10 million to anyone that could design a device to mimic Dr McCoy's trusted tricorder. It launched in 2013 with 312 teams registering, In May last year that was reduced to seven finalists. The winner will be announced early in 2017 and, assuming the device works, medicine would have boldly gone where no-one had gone before.


Recommended

by NEWSROOM AI
Read More
Why you should read the Bill and Melinda Gates Foundation annual letter

Why you should read the Bill and Melinda Gates Foundation annual letter

For the last decade, the letter has tracked how the world has been improving.

Robocalls: the good, the bad and the ugly

Robocalls: the good, the bad and the ugly

Before Robocops we will need to deal with Robocallers.

Technology is neither good nor evil. How we use it makes it one or the other

Technology is neither good nor evil. How we use it makes it one or the other

New digital products intended to solve problems can also create new ones.

How mushrooms and milk might solve a plastic packaging problem

How mushrooms and milk might solve a plastic packaging problem

Plastic can be found everywhere on the planet, often as rubbish. How can we get rid of it?

Does the world need a social credit score to get us to behave?

Does the world need a social credit score to get us to behave?

China thinks so. It may sound like a scary movie, but it's also very likely to happen.

The impact of a fire in the US might spare South Africa from getting burned

The impact of a fire in the US might spare South Africa from getting burned

Eskom is in big trouble, but not as much as the Pacific Gas and Electric Company.

Popular articles
[WATCH] Refentse Morake continues breaking cultural barriers through his music

[WATCH] Refentse Morake continues breaking cultural barriers through his music

The singer who says he's 'on the border of being Afrikaans and being African' joined Azania Mosaka for this week's #702Unplugged.

What happens to our bodies if we cut out sugar

What happens to our bodies if we cut out sugar

Naked Scientist Chris Smith explains.

Why did Jussie Smollet fake his own attack? Eusebius and listeners weigh in

Why did Jussie Smollet fake his own attack? Eusebius and listeners weigh in

Eusebius McKaiser facilitates a debate on whether or not American actor Jussie Smollet faked his own attack.

[WATCH] SANDF members hilariously mess up a supposedly easy practice run

[WATCH] SANDF members hilariously mess up a supposedly easy practice run

Khabazela shares tweets and Facebook posts that have gone viral.

[LISTEN] Wife of Vele Investments' Madzonga flatly denies VBS involvement

[LISTEN] Wife of Vele Investments' Madzonga flatly denies VBS involvement

Vele Investments CEO Robert Madzonga's estranged wife Khosi shares her side of the story on the VBS saga.

Is EOH corrupt? Is that why Microsoft ran for the hills? Its CEO explains…

Is EOH corrupt? Is that why Microsoft ran for the hills? Its CEO explains…

The Money Show’s Bruce Whitfield interviews Stephen van Coller, CEO at EOH Holdings.

'R23 million for rent a month seems huge. I don't think we could've done better'

'R23 million for rent a month seems huge. I don't think we could've done better'

The Money Show’s Bruce Whitfield interviews Adrian Gore, founder and Group Chief Executive Officer at Discovery Limited.